Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.
Saved in:
| Title: | Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. |
|---|---|
| Authors: | Chan LC; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Lee HK; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Wang L; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Wang H; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Filler SG; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Ciranna A; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Abdelhady W; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Xiong YQ; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Li L; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA., Gonzales RA; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA., Ruffin F; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Fowler VG Jr; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA.; Duke Clinical Research Institute, Durham, NC 27708, USA., Bayer AS; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Proctor RA; School of Medicine and Public Health, University of Wisconsin, Madison, WI 53726, USA., Yeaman MR; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA. |
| Corporate Authors: | MRSA Systems Immunobiology Group (MSIG) |
| Source: | Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2026 Mar 25; Vol. 15 (4). Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2079-6382 |
|---|---|
| DOI: | 10.3390/antibiotics15040332 |
